Your browser doesn't support javascript.
loading
Evaluation of Drug-Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors.
Occhipinti, Mario; Brambilla, Marta; Galli, Giulia; Manglaviti, Sara; Giammaruco, Maristella; Prelaj, Arsela; Ferrara, Roberto; De Toma, Alessandro; Proto, Claudia; Beninato, Teresa; Zattarin, Emma; Lo Russo, Giuseppe; Gelibter, Alain Jonathan; Simmaco, Maurizio; Preissner, Robert; Garassino, Marina Chiara; De Braud, Filippo; Marchetti, Paolo.
Affiliation
  • Occhipinti M; Thoracic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • Brambilla M; Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy.
  • Galli G; Thoracic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • Manglaviti S; Thoracic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • Giammaruco M; Thoracic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • Prelaj A; Medical Oncology Unit B, Policlinico Umberto I, Sapienza University of Rome, Viale del Policlinico, 155, 00161 Roma, Italy.
  • Ferrara R; Thoracic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • De Toma A; Department of Electronics, Information, and Bioengineering, Politecnico di Milano, Via Giuseppe Ponzio, 34, 20133 Milano, Italy.
  • Proto C; Thoracic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • Beninato T; Thoracic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • Zattarin E; Thoracic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • Lo Russo G; Thoracic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • Gelibter AJ; Thoracic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • Simmaco M; Thoracic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • Preissner R; Medical Oncology Unit B, Policlinico Umberto I, Sapienza University of Rome, Viale del Policlinico, 155, 00161 Roma, Italy.
  • Garassino MC; Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University of Rome, Sant'Andrea University Hospital, Via di Grottatossa, 1035, 00189 Rome, Italy.
  • De Braud F; Department of Advanced Molecular Diagnostics, Sapienza University of Rome, Sant'Andrea Hospital, Via di Grottatossa, 1035, 00189 Rome, Italy.
  • Marchetti P; Institute of Physiology and Science-IT, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany.
J Pers Med ; 11(5)2021 May 18.
Article in En | MEDLINE | ID: mdl-34069851
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Pers Med Year: 2021 Document type: Article Affiliation country: Italia Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Pers Med Year: 2021 Document type: Article Affiliation country: Italia Country of publication: Suiza